wegovy novo nordisk - Search News

News

Novo Nordisk shares plunge

CBS News on MSN · 15h

Novo Nordisk shares fall 20% after company names new CEO and lowers its financial outlook

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs.

Reuters on MSN · 20h

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to revive sales and a share price hit by worries the maker of weight-loss drug Wegovy is falling behind in a race it started.

Bloomberg on MSN · 17h

Novo Falls by Record as Wegovy Slumps and Insider Named CEO

Novo Nordisk A/S named its head of international operations as chief executive officer after slumping weight-loss drug sales led to a profit warning that wiped $93 billion off its market value.

Wegovy maker warns of slower profits

Reuters on MSN · 14h

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the obesity drug market.

Benzinga · 19h

Novo Nordisk Implodes After Wegovy Warning—Is The Weight-Loss Bubble Bursting?

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a new CEO.

Wegovy maker warns of slower profits as rivals bite

The Danish-maker of Wegovy and Ozempic has warned that its full-year sales and profits will not grow as quickly as expected as more "knock-off" weight-loss drugs emerge. Novo Nordisk's share price tumbled by more than 20% as it cut its outlook and named a new chief executive to replace Lars Fruergaard Jørgensen,

12hon MSN

Ozempic maker Novo Nordisk on track for its worst day since Black Monday

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

13hon MSN

Novo Nordisk Shares Plummet as Competition Weighs on Sales

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

20hon MSN

Novo Nordisk Cut Its Outlook and Named a New CEO. Its Stock Is Plummeting

U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and ...

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

17hon MSN

Novo's new CEO faces sceptical investors with Wegovy US sales in focus

Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...

9h

Novo Nordisk stock crashes after company cuts sales, profit outlook on weight-loss drug competition

Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

Novo Nordisk's Wegovy: Battling Market Challenges Amid Rising Prescriptions

The U.S. FDA ban on compounded versions of Novo Nordisk's Wegovy has increased its prescriptions by 33%. Despite this, ...

1don MSN

Novo Nordisk faces 'show me' moment to boost Wegovy growth after US copycat ban

A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results